Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations.

Journal Article (Journal Article;Review)

The emphasis in contemporary medical oncology has been "precision" or "personalized" medicine, terms that imply a strategy to improve efficacy through targeted therapies. Similar attempts at precision are occurring in surgical oncology. Sentinel lymph node (SLN) mapping has recently been introduced into the surgical staging of endometrial cancer with the goal to reduce morbidity associated with comprehensive lymphadenectomy, yet obtain prognostic information from lymph node status. The Society of Gynecologic Oncology's (SGO) Clinical Practice Committee and SLN Working Group reviewed the current literature for preparation of this document. Literature-based recommendations for the inclusion of SLN assessment in the treatment of patients with endometrial cancer are presented. This article examines.

Full Text

Duke Authors

Cited Authors

  • Holloway, RW; Abu-Rustum, NR; Backes, FJ; Boggess, JF; Gotlieb, WH; Jeffrey Lowery, W; Rossi, EC; Tanner, EJ; Wolsky, RJ

Published Date

  • August 2017

Published In

Volume / Issue

  • 146 / 2

Start / End Page

  • 405 - 415

PubMed ID

  • 28566221

Pubmed Central ID

  • PMC6075736

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2017.05.027


  • eng

Conference Location

  • United States